Synlogic to merge with Caldera Therapeutics; Synlogic shareholders to own ~2.3% of combined company

SYNLOGIC, INC.

Merger with Caldera; Synlogic shareholders to receive shares in new parent, owning ~2.3% on fully diluted basis.
Caldera equityholders (pre-money) to own ~62.8%; concurrent $278M financing investors own ~34.9%.
Synlogic valued at $18M (assuming $6M net cash); Caldera valued at $500M.
Support agreements from 50.9% of Synlogic stockholders and 72.6% of Caldera stockholders.
Warrant amendments reduce exercise price to $0.70/share and remove cash redemption right.

item 1.01 item 3.03 item 5.01 item 7.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.